Used in serums for the look of stubborn discolouration and post-blemish marks.
More on this ingredient: read the guide.
Read the neutral reference entry →Compatible in principle — tranexamic acid is not pH-dependent and does not deactivate a retinoid — but it is another active on skin that is already adjusting. Introduce them weeks apart rather than together, and split across AM/PM if either stings.
A common tone-focused pairing: they act on pigmentation by different routes, so formulators frequently combine them. Well tolerated for most people, though both can sting on a compromised barrier.
A frequently recommended combination for uneven tone — niacinamide limits pigment transfer while tranexamic acid works further upstream. Neither is pH-dependent, so layering order is not critical.
Both are used for post-inflammatory marks and both are gentler than the classic brighteners. Commonly layered; azelaic acid also calms the redness side, which tranexamic acid does not address.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.